Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. (Q52826331)
Jump to navigation
Jump to search
scientific article published in June 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. |
scientific article published in June 2000 |
Statements
Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. (English)
1 reference
1 reference
Blagosklonny MV
1 reference
Poy G
1 reference
Zhan Z
1 reference
Knutsen T
1 reference
Fojo T
1 reference
1 June 2000
1 reference
1 reference
19
1 reference
27
1 reference
3078-3085
1 reference
Identifiers
1 reference